1. Home
  2. GNT vs BDSX Comparison

GNT vs BDSX Comparison

Compare GNT & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNT
  • BDSX
  • Stock Information
  • Founded
  • GNT 2011
  • BDSX 2005
  • Country
  • GNT United States
  • BDSX United States
  • Employees
  • GNT N/A
  • BDSX N/A
  • Industry
  • GNT Finance/Investors Services
  • BDSX Precision Instruments
  • Sector
  • GNT Finance
  • BDSX Health Care
  • Exchange
  • GNT Nasdaq
  • BDSX Nasdaq
  • Market Cap
  • GNT 97.4M
  • BDSX 115.4M
  • IPO Year
  • GNT N/A
  • BDSX 2020
  • Fundamental
  • Price
  • GNT $6.01
  • BDSX $0.35
  • Analyst Decision
  • GNT
  • BDSX Strong Buy
  • Analyst Count
  • GNT 0
  • BDSX 4
  • Target Price
  • GNT N/A
  • BDSX $2.83
  • AVG Volume (30 Days)
  • GNT 40.9K
  • BDSX 523.2K
  • Earning Date
  • GNT 01-01-0001
  • BDSX 05-13-2025
  • Dividend Yield
  • GNT 6.61%
  • BDSX N/A
  • EPS Growth
  • GNT N/A
  • BDSX N/A
  • EPS
  • GNT 0.95
  • BDSX N/A
  • Revenue
  • GNT N/A
  • BDSX $71,323,000.00
  • Revenue This Year
  • GNT N/A
  • BDSX $32.90
  • Revenue Next Year
  • GNT N/A
  • BDSX $24.65
  • P/E Ratio
  • GNT $5.36
  • BDSX N/A
  • Revenue Growth
  • GNT N/A
  • BDSX 45.30
  • 52 Week Low
  • GNT $4.59
  • BDSX $0.45
  • 52 Week High
  • GNT $5.40
  • BDSX $2.04
  • Technical
  • Relative Strength Index (RSI)
  • GNT 56.12
  • BDSX 27.69
  • Support Level
  • GNT $5.87
  • BDSX $0.51
  • Resistance Level
  • GNT $6.05
  • BDSX $0.58
  • Average True Range (ATR)
  • GNT 0.08
  • BDSX 0.06
  • MACD
  • GNT 0.01
  • BDSX -0.01
  • Stochastic Oscillator
  • GNT 70.00
  • BDSX 1.15

About GNT GAMCO Natural Resources Gold & Income Trust

GAMCO Natural Resources, Gold & Income Trust is a non-diversified closed-end management investment company. The company's primary investment objective is to provide a high level of current income from interest, dividends, and options premiums with its secondary objective being capital appreciation. Under normal market conditions, the company invests majority of its assets in securities of companies principally engaged in the natural resources and gold industries, and also engages in writing covered call options on the underlying equity securities. Its portfolio consists of securities from different sectors such as metals and mining, energy and energy services, specialty chemicals, agriculture, healthcare, machinery, food and beverage, and others.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: